ckra

Study Information

The purpose of this study is to evaluate the safety and effectiveness of an investigational vaccine for cytomegalovirus (CMV) in adults ages 18 to 40.

Duration: Approximately 18 months

Number of visits to AMR Lexington: 12, plus 6 telephone calls 

Compensation: $1,070

Qualifications: Qualified participants must be between the ages of 18 and 40 years old and be in general good health.  Other criteria also apply.

 

CMV Vaccine Study

If you are interested in participating in this study, please fill out the form below. This will help us determine if you meet some of the initial criteria necessary to participate. We will contact you within 48 hours to follow up and clarify any questions that you, or we, may have. If it is determined that you meet all of the initial criteria, you may be scheduled to come in for your first visit, which is considered a screening visit. At this visit, Dr. Adams and the study coordinator will determine if you meet all of the criteria required to participate. Per AMR Lexington's privacy policy, all of your personal information that we have obtained will be kept in our secure database, which can only be accessed by authorized personnel, unless given your permission or except as required by law.

Prequalifying Questionnaire

×

Make an appointment and we’ll contact you.